Clinical variants include mucosal-only disease (which correlates with circulating anti-Dsg3 autoantibodies), cutaneous-only disease (anti-Dsg1 antibody predominant), or more frequently, mucocutaneous involvement (presence of both anti-Dsg1 and anti-Dsg3 antibodies). Here, DSG3 is linked to glycogen storage disease VI.